Literature DB >> 10422201

Cytokines in alcoholic liver disease.

C J McClain1, S Barve, I Deaciuc, M Kugelmas, D Hill.   

Abstract

Cytokines are low-molecular-weight mediators of cellular communication produced by multiple cell types in the liver, with the Kupffer cell critically important. Inflammatory cytokines such as tumor necrosis factor, interleukin-1, and interleukin-8, and hepatic acute-phase cytokines such as interleukin-6 play a role in modulating certain metabolic complications in alcoholic liver disease and probably play a role in the liver injury of alcoholic liver disease. Two potential inducers of cytokine production in alcoholic liver disease are endotoxin and reactive oxygen species generated after ethanol metabolism. Cytotoxic cytokines likely induce liver cell death by both necrosis and apoptosis in alcoholic liver disease. Anticytokine therapy has been highly successful in attenuating cell injury/death in a variety of toxin-induced models of liver injury, including alcohol-related liver injury. Anticytokine therapy has been used successfully in humans in disease processes such as Crohn's disease and rheumatoid arthritis. There is an emerging rationale for use of anticytokine therapy in alcoholic liver disease, with the goal of maintaining beneficial effects of cytokines and inhibition of the deleterious effects of these potentially toxic agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422201     DOI: 10.1055/s-2007-1007110

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  104 in total

Review 1.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 3.  Alcoholic liver disease and malnutrition.

Authors:  Craig J McClain; Shirish S Barve; Ashutosh Barve; Luis Marsano
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

4.  The Prevalence, Incidence, and Progression of Hand Osteoarthritis in Relation to Body Mass Index, Smoking, and Alcohol Consumption.

Authors:  Ida K Haugen; Karin Magnusson; Aleksandra Turkiewicz; Martin Englund
Journal:  J Rheumatol       Date:  2017-07-15       Impact factor: 4.666

Review 5.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 6.  Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.

Authors:  Courtney S Schaffert; Michael J Duryee; Carlos D Hunter; Bartlett C Hamilton; Amy L DeVeney; Mary M Huerter; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 7.  Impact of asialoglycoprotein receptor deficiency on the development of liver injury.

Authors:  Serene M L Lee; Carol A Casey; Benita L McVicker
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 8.  Pathogenic interactions between alcohol and hepatitis C.

Authors:  Gyongyi Szabo
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

Authors:  Aimin Xu; Yu Wang; Hussila Keshaw; Lance Yi Xu; Karen S L Lam; Garth J S Cooper
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure.

Authors:  Nataly Shulga; John G Pastorino
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.